Analysis using UALCAN database indicated that the expression of PFKFB4 was significantly upregulated in NSCLC samples (Fig. 3A), and it was negatively correlated with the overall survival time of NSCLC patients (Fig. 3B). This evidence concerns the gene PFKFB4 and non-small cell lung carcinoma.